Company Overview and News

 
Trading ideas: Chin Teck, HLT Global, Inari, MPI, Prestariang, Weida

2018-01-30 thestar.com.my
KUALA LUMPUR: Chin Teck Plantations Bhd , HLT Global, Inari Amerton Bhd, Malaysian Pacific Industries Bhd (MPI), Prestariang Bhd and Weida (M) Bhd are among the stocks to watch on Tuesday, according to JF Apex Research.

 
Bearish sentiment keeps KLCI below 1,700-level

2017-02-28 theedgemarkets
KUALA LUMPUR (Feb 28): The FBM KLCI remained pressured and below the crucial 1,700-point level at the midday break today, as sentiment stayed bearish.

 
KLCI retreats as sellers outpace buyers

2017-02-15 theedgemarkets
KUALA LUMPUR (Feb 15): The FBM KLCI retreated at the midday break today as sellers outpaced buyers.

 
Affin Hwang Capital ups CPO price forecast for 2017, 2018 to RM2,600 per MT

2017-02-03 theedgemarkets
KUALA LUMPUR (Feb 3): Affin Hwang Capital Research has revised upward its average crude palm oil (CPO) price forecast to RM2,600 per metric tonne (MT) from RM2,400 per MT for 2017 and 2018, amid tight global supply and weakness in the ringgit.

 
Muted gains for KLCI in line with tentative regional markets

2017-02-03 theedgemarkets
KUALA LUMPUR (Feb 3): The FBM KLCI notched up limited gains at mid-morning today, in line with the more tentative regional markets.

 
KLCI edges up as banks and blue chips lift

2017-02-03 theedgemarkets
KUALA LUMPUR (Feb 3): The FBM KLCI edged up in early trade against the backdrop of a tentative start at most regional markets, lifted by index-linked banking and blue chip stocks.

 
KLCI reverses loss, rises 0.36%

2017-02-02 theedgemarkets
KUALA LUMPUR (Feb 2): The FBM KLCI reversed its earlier losses at mid-morning and rose 0.36% in line with the gains at most regional markets, lifted by index-linked plantation stocks.

 
KLCI gains 0.49% as select blue chips lift

2016-12-01 theedgemarkets
KUALA LUMPUR (Dec 1): The FBM KLCI gained 0.49% at the midday break today, lifted by select blue chips on slightly improved sentiment as crude oil prices rebounded.

 
KLCI pares loss, but sentiment turns bearish

2016-11-11 theedgemarkets
KUALA LUMPUR (Nov 11): The FBM KLCI pared some of its loss at the midday break today, but the benchmark index was still down 0.98% as sentiment turned bearish in line with the regional markets.

 
Bloodbath at Bursa as Trump takes emphatic lead

2016-11-09 theedgemarkets
KUALA LUMPUR (Nov 9): Stocks at Bursa Malaysia tumbled as Republican candidate Donald Trump took an emphatic lead over Democrat Hillary Clinton in the hotly-contested U.S. presidential election, dragging global markets and currencies.

 
KLCI stutters as Trump takes early lead over Clinton

2016-11-09 theedgemarkets
KUALA LUMPUR (Nov 9): The FBM KLCI stuttered at mid-morning and reversed its earlier gains as Republican candidate Donald Trump took an early lead against Democrat Hillary Clinton, causing jitters across regional markets.

 
KLCI pares gains as decliners outpace advancers

2016-10-19 theedgemarkets
KUALA LUMPUR (Oct 19): The FBM KLCI pared some of its gaisn at the midday break today as decliners overtook advancers at the local bourse.

 
KLCI reverses loss, edges up in line with region

2016-10-19 theedgemarkets
KUALA LUMPUR (Oct 19): The FBM KLCI reversed its losses at mid-morning and edged up in line with the regional markets.

 
KLCI dips 0.34% as sellers outpace buyers

2016-08-02 theedgemarkets
KUALA LUMPUR (Aug 2): The FBM KLCI dipped 0.34% at the midday break today as sellers outpaced buyers, in line with the retreat at most regional markets.

 
KLCI pares loss, stays tepid in line with region

2016-08-02 theedgemarkets
KUALA LUMPUR (Aug 2): The FBM KLCI pared some of its losses at mid-morning today, but sentiment at the local market stayed tepid in line with the regional markets.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...